Skip to main content
. 2022 Jan 15;19(1):74–89. doi: 10.20892/j.issn.2095-3941.2020.0218

Figure 3.

Figure 3

The statistics of the validation information for the top group and the random group. The top 20 diseases for each drug were extracted as the top group and evaluated against 3 databases (KEGG, DrugBank, and ClinicalTrials.gov) as well as PubMed to determine whether the drug-disease relationships had been validated. A random group of 20 diseases was also extracted for comparison.